Dr. Leonard and colleagues found that rituximab (Rituxan) plus lenalidomide (Revlimid) elicited superior progression-free survival for patients with relapsed/refractory indolent non-Hodgkin’s lymphoma.
Dr. Jedd Wolchok has been appointed as the Meyer Director of the Sandra and Edward Meyer Cancer Center and Dr. Taha Merghoub as Deputy Director.
The study analyzed the use of autologous stem cell transplantation (ASCT), a type of bone marrow transplantation that uses a patient’s own cells, and found that the usage of ASCT can be low in some patient settings.
This award was initiated by Dr. Ralph Nachman in 2002 to recognize outstanding research during fellowship training.
The interdepartmental and interdisciplinary celebration of quality and patient safety initiatives included 27 projects from 13 departments across WCM, Lower Manhattan Hospital, NYP/Queens, and NYP/Brooklyn Methodist.
The award recognizes the tremendous research conducted by WCM investigators to improve the health of underrepresented minorities and/or to reduce health disparities.
The Weill Department of Medicine has announced five winners who will receive Fund for the Future (FFF) awards.
Another success story under Dr. Koen van Besien’s leadership of the Bone Marrow Transplantation Program in the Division of Hematology and Medical Oncology, WDOM, has been highlighted on NPR.
Interviewed by Dr. Jonathan LaPook of CBS News’s Sunday Morning, Dr. Gail Roboz’s patient, Delia Ephron, shared her experiences after learning she had leukemia in 2017.
Drs. Koen Van Besien, Jingmei Hsu, and Marshall Glesby have led a clinical trial involving a patient living with HIV who has now been free of the virus for 14 months.
